Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer–the Experience of a Tertiary Cancer Center

Overview of attention for article published in Frontiers in Pharmacology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer-the Experience of a Tertiary Cancer Center https://t.co/lwcG4IbeMg #colorectalcancer #oncology https://t.co/oDVW1RdT3z

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.